The effectiveness of second- and-third-line biologics in perianal Crohn’s disease—a multicenter propensity score-matched study

BACKGROUND & AIMS: Anti-tumor necrosis factor-alpha inhibitors (anti-TNFs) are the established treatment for perianal Crohn's disease (pCD), but relapse and non-response are common. Data on 2nd- and 3rd-line biologics are limited. We present the first direct comparison of 2nd - and 3rd -lin...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Shani Uria
State Monica
Mateescu Radu Bogdan
Davidoiu Ana-Maria
Negreanu Lucian
Silva Isabel
Magro Fernando
Lees Charlie W
Plevris Nikolas
Roblin Xavier
Castellet-Farrus Silvia
Gonzalez Lama Yago
Wang Shanshan
Farkas Bernadett
Farkas Klaudia
et al
Dokumentumtípus: Cikk
Megjelent: 2025
Sorozat:JOURNAL OF CROHNS & COLITIS 19 No. 6
Tárgyszavak:
doi:10.1093/ecco-jcc/jjaf099

mtmt:36192916
Online Access:http://publicatio.bibl.u-szeged.hu/37233

Hasonló tételek